マーケットレポート詳細

医療診断用AI(人工知能)の世界市場:コンポーネント別、用途別2028年予測

Artificial Intelligence (AI) in Medical Diagnostics Market by Modality (CT, X-Ray, MRI, Ultrasound), Application (IVD, Radiology, CNS, CVS, Ob/Gyn), User (Hospital, Labs), Unmet Need, Key Stakeholders & Buying Criteria - Global Forecast to 2028

出版元:MarketsandMarkets   出版元について
発行年:2023年10月
定価 :Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文327ページになります。
商品コード:MAM3441

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

医療診断用AIの世界市場規模は2023年で13億ドル、2028年に37億ドル、市場の平均年成長率は23.2%増で推移する見通しです。

レポートは医療診断用AIの世界市場について2028年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測(コンポーネント別市場、用途別市場、等)を中心に構成されています。また競合状況、主要企業情報(11社)、ケーススタディ、特許分析などの分析も加味し、医療診断用AI市場の動向および今後成長性を詳細にレポートしています。

【レポート構成概要】

◆医療診断用AIの世界市場予測2017-2028年

市場規模(US$)

◆コンポーネント別、市場-2028年

ソフトウェア
サービス
ハードウェア
・プロセッサ
-MPU
-GPU(画像処理装置)
-FPGA
-ASIC

・メモリ
・ネットワーク
-アダプタ
-スイッチ
-インターコネクト
※(市場規模US$)

◆用途別、市場-2028年

専門分野別、In vivo診断
・放射線科
・心臓病学
・神経内科
・産婦人科
・眼科
・その他

モダリティ別、In vivo診断
・CT
・X線
・MRI
・超音波
・その他

IVD(体外診断)
※(市場規模US$)

◆エンドユーザー別、市場-2028年

・病院
・画像診断センター
・診断ラボラトリー
・その他エンドユーザー
※(市場規模US$)

◆主要国地域別市場-2028年

北米
・米国、カナダ
欧州
・ドイツ、フランス、英国
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
中南米
中東アフリカ
※国地域別に全セグメントの細分化データ掲載、詳細は目次参照

◆市場分析

・市場ダイナミクス(促進要因、障壁、機会、課題)
・バリューチェーン分析
・エコシステムマッピング
・ケーススタディ
・技術分析
・業界構造分析
・産業傾向
・貿易分析
・プライシング分析
・特許分析
・競合状況
・市場シェア分析

◆医療診断用AIの主要企業プロフィール動向

・MICROSOFT
・NVIDIA CORPORATION
・MERATIVE
・GOOGLE (ALPHABET, INC)
・INTEL CORPORATION
・SIEMENS HEALTHINEERS
・GE HEALTHCARE
・ADVANCED MICRO DEVICES, INC
・KONINKLIJKE PHILIPS NV
・DIGITAL DIAGNOSTICS, INC
・INFORMAI
その他企業
・HEARTFLOW, INC
・ENLITIC, INC
・AIDENCE
・BUTTERFLY NETWORK, INC
・NANO X IMAGING LTD
・VIZAI, INC
・QUIBIM
・QUREAI
・THERAPIXEL
・AIDOC
・LUNIT, INC
・ECHONOUS, INC
・ICOMETRIX
・BRAINOMIX

(全327頁)
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次)

1      INTRODUCTION

1.1             STUDY OBJECTIVES
1.2             MARKET DEFINITION
1.2.1              INCLUSIONS AND EXCLUSIONS
1.3             MARKET SCOPE
1.3.1              MARKETS COVERED   46
1.3.2              YEARS CONSIDERED   46
1.3.3              CURRENCY CONSIDERED
1.4             STAKEHOLDERS
1.5             SUMMARY OF CHANGES
1.6             RECESSION IMPACT

2      RESEARCH METHODOLOGY

2.1             RESEARCH DATA
・     FIGURE 1            RESEARCH DESIGN
2.1.1              SECONDARY DATA
2.1.1.1            KEY DATA FROM SECONDARY SOURCES
2.1.2              PRIMARY DATA
・     FIGURE 2            PRIMARY SOURCES
2.1.2.1            KEY DATA FROM PRIMARY SOURCES
2.1.2.2            KEY INDUSTRY INSIGHTS
・     FIGURE 3            BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,  AND REGION
2.2             MARKET SIZE ESTIMATION
・     FIGURE 4            RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
・     FIGURE 5            MARKET SIZE ESTIMATION
・     TABLE 1              FACTOR ANALYSIS
・     FIGURE 6            AI IN MEDICAL DIAGNOSTICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)
・     FIGURE 7            CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
・     FIGURE 8            TOP-DOWN APPROACH
2.3             MARKET DATA ESTIMATION AND TRIANGULATION
・     FIGURE 9            DATA TRIANGULATION METHODOLOGY
2.4             ASSUMPTIONS   60
2.5             LIMITATIONS   60
2.5.1              SCOPE-RELATED LIMITATIONS
2.5.2              METHODOLOGY-RELATED LIMITATIONS
2.6             RISK ASSESSMENT
・     TABLE 2              RISK ASSESSMENT: AI IN MEDICAL DIAGNOSTICS MARKET
2.7             AI IN MEDICAL DIAGNOSTICS MARKET: RECESSION IMPACT ANALYSIS

3      EXECUTIVE SUMMARY

・     FIGURE 10          AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2023 VS. 2028 (USD MILLION)
・     FIGURE 11          AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2023 VS. 2028 (USD MILLION)
・     FIGURE 12          AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2023 VS. 2028 (USD MILLION)
・     FIGURE 13          GEOGRAPHICAL SNAPSHOT OF AI IN MEDICAL DIAGNOSTICS MARKET

4      PREMIUM INSIGHTS

4.1             AI IN MEDICAL DIAGNOSTICS MARKET OVERVIEW
・     FIGURE 14          RISING VOLUME OF DIAGNOSTIC IMAGING PROCEDURES AND INFLUX OF  BIG DATA TO DRIVE MARKET
4.2             NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET,  BY APPLICATION AND COUNTRY (2022)
・     FIGURE 15          IN VIVO DIAGNOSTICS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICA  IN 2022
4.3             AI IN MEDICAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・     FIGURE 16          ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE
4.4             AI IN MEDICAL DIAGNOSTICS MARKET: REGIONAL MIX
・     FIGURE 17          ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.5             AI IN MEDICAL DIAGNOSTICS MARKET:  DEVELOPED MARKETS VS. EMERGING ECONOMIES
・     FIGURE 18          EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD

5      MARKET OVERVIEW

5.1             INTRODUCTION
・     FIGURE 19          AI IN MEDICAL DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.1.1              DRIVERS
5.1.1.1            INFLUX OF BIG DATA
5.1.1.2            GROWING CROSS-INDUSTRY PARTNERSHIPS & COLLABORATIONS
5.1.1.3            INCREASING DEMAND FOR AI-BASED SOLUTIONS TO REDUCE WORK PRESSURE ON RADIOLOGISTS
5.1.1.4            RISING GOVERNMENT INITIATIVES TO SUPPORT AI-BASED TECHNOLOGIES   70
5.1.1.5            AVAILABILITY OF FUNDING FOR AI-BASED STARTUPS
5.1.2              RESTRAINTS
5.1.2.1            INADEQUATE AI WORKFORCE AND AMBIGUOUS REGULATORY GUIDELINES FOR MEDICAL SOFTWARE
5.1.3              OPPORTUNITIES
5.1.3.1            UNTAPPED EMERGING MARKETS
5.1.3.2            INCREASING FOCUS ON DEVELOPING HUMAN-AWARE AI SYSTEMS
5.1.4              CHALLENGES
5.1.4.1            RELUCTANCE TO ADOPT AI-BASED TECHNOLOGIES
5.1.4.2            BUDGETARY CONSTRAINTS
5.1.4.3            UNSTRUCTURED HEALTHCARE DATA
5.1.4.4            DATA PRIVACY CONCERNS
5.1.4.5            LIMITED INTEROPERABILITY
5.2             TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS
・     FIGURE 20          REVENUE SHIFT & NEW REVENUE POCKETS FOR AI IN MEDICAL DIAGNOSTICS
5.3             VALUE CHAIN ANALYSIS
・     FIGURE 21          AI IN MEDICAL DIAGNOSTICS MARKET: VALUE CHAIN
5.3.1              UPSTREAM
5.3.2              MID-STREAM
5.3.3              DOWNSTREAM
5.4             ECOSYSTEM MAPPING
・     FIGURE 22          AI IN MEDICAL DIAGNOSTICS MARKET: ECOSYSTEM
5.4.1              ROLE IN ECOSYSTEM    78
5.5             CASE STUDIES
5.5.1              MAYO CLINIC INTEGRATES AI-ENABLED DIGITAL DIAGNOSTICS AND BOOSTS MEDICAL RESEARCH WITH GOOGLE CLOUD PLATFORM
5.5.2              RESOLVING CHALLENGES OF UNDERSTAFFED WORKFORCE AND BACKLOG WITH VEYE LUNG NODULES
5.5.3              NVIDIA AI ENTERPRISE SOFTWARE AND GPUS HELP IMPROVE PERFORMANCE AND PRECISION OF TUMOR TARGETING
5.5.4              ZHEJIANG UNIVERSITY AND ZHEJIANG DE IMAGE SOLUTIONS USE INTEL AI SOLUTION TO PROCESS ULTRASOUND
5.5.5              WAITEMATA DISTRICT HEALTH BOARD PROJECT UTILIZES PRECISION-DRIVEN HEALTH SOLUTIONS
5.6             TECHNOLOGY ANALYSIS
5.6.1              MACHINE LEARNING   81
5.6.2              NATURAL LANGUAGE PROCESSING
5.6.3              COMPUTER VISION   81
・     TABLE 3              TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
5.7             PORTER’S FIVE FORCES ANALYSIS
・     TABLE 4              AI IN MEDICAL DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1              THREAT OF NEW ENTRANTS
5.7.2              THREAT OF SUBSTITUTES
5.7.3              BARGAINING POWER OF SUPPLIERS
5.7.4              BARGAINING POWER OF BUYERS
5.7.5              INTENSITY OF COMPETITIVE RIVALRY
5.8             INDUSTRY TRENDS
5.8.1              ARTIFICIAL INTELLIGENCE IN HEALTHCARE
5.8.1.1            KEY TO AI IN HEALTHCARE: DATA
5.8.1.2            AR AND MR IN HEALTHCARE SETTINGS
5.8.1.3            HEALTHCARE PRIVACY AND SECURITY IN 2022
5.8.1.4            GROWING DEMAND FOR AI AMONG COMPANIES OFFERING AT-HOME IVD TESTING SERVICES
5.9             TRADE ANALYSIS
・     FIGURE 23          EXPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN AI IN MEDICAL DIAGNOSTICS MARKET 2022 (USD THOUSAND)
・     FIGURE 24          IMPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN AI IN MEDICAL DIAGNOSTICS MARKET 2022 (USD THOUSAND)
5.10          TARIFF AND REGULATORY ANALYSIS
5.10.1            TARIFF FOR AI IN MEDICAL DIAGNOSTICS HARDWARE
・     TABLE 5              TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY US, 2022
・     TABLE 6              TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY CHINA, 2022
・     TABLE 7              TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY GERMANY, 2020
5.10.2            REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・     TABLE 8              NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・     TABLE 9              EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・     TABLE 10            ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・     TABLE 11            REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND  OTHER ORGANIZATIONS
5.10.3            NORTH AMERICA
・     FIGURE 25          ALGORITHMS CLEARED BY US FDA, 2008 TO 2023
5.10.3.1          HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 (HIPAA)
5.10.3.2          HEALTH INFORMATION TECHNOLOGY FOR ECONOMIC AND CLINICAL HEALTH ACT OF 2009 (HITECH)
5.10.3.3          CONSUMER PRIVACY PROTECTION ACT OF 2017
5.10.3.4          NATIONAL CYBERSECURITY PROTECTION ADVANCEMENT ACT OF 2015
5.10.3.5          FUTURE OF LIFE INSTITUTE’S ASILOMAR AI PRINCIPLES
5.10.4            EUROPE
5.10.4.1          EUROPEAN MEDICAL DEVICES REGULATION (EU) 2017/745 AND IN-VITRO DIAGNOSTIC MEDICAL DEVICES REGULATION (EU) 2017/746, IN COMBINATION WITH GENERAL DATA PROTECTION REGULATION 2016/679
5.10.4.2          AI ACT (ARTIFICIAL INTELLIGENCE ACT)
5.10.5            ASIA PACIFIC
5.10.5.1          CYBERSECURITY LAW OF THE PEOPLE’S REPUBLIC OF CHINA
5.10.6            REST OF THE WORLD   93
5.10.6.1          PROTECTION OF PERSONAL INFORMATION ACT
5.11          PRICING ANALYSIS
・     FIGURE 26          AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY HARDWARE (PROCESSOR)
・     TABLE 12            AVERAGE SELLING PRICE OF PROCESSORS, BY TYPE
5.11.1            AVERAGE SELLING PRICE TREND
5.12          PATENT ANALYSIS
5.12.1            PATENT PUBLICATION TRENDS FOR ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS
・     FIGURE 27          PATENT PUBLICATION TRENDS (2019-2023)
5.12.2            INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
・     FIGURE 28          TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR AI IN MEDICAL DIAGNOSTICS (2019-2023)
・     TABLE 13            LIST OF PATENTS/PATENT APPLICATIONS IN AI IN MEDICAL DIAGNOSTICS MARKET
5.13          KEY CONFERENCES AND EVENTS (2023–2024)
・     TABLE 14            AI IN MEDICAL DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
5.14          KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1            KEY STAKEHOLDERS IN BUYING PROCESS
・     TABLE 15            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AI IN MEDICAL DIAGNOSTICS
・     FIGURE 29          INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
・     TABLE 16            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
5.14.2            BUYING CRITERIA   100
・     FIGURE 30          KEY BUYING CRITERIA FOR END USERS
・     TABLE 17            KEY BUYING CRITERIA FOR END USERS
5.15          UNMET NEEDS: AI IN MEDICAL DIAGNOSTICS MARKET
・     TABLE 18            AI IN MEDICAL DIAGNOSTICS MARKET: UNMET NEEDS
5.16          END-USER EXPECTATIONS
・     TABLE 19            AI IN MEDICAL DIAGNOSTICS MARKET: END-USER EXPECTATIONS
5.17          REIMBURSEMENT SCENARIO
・     TABLE 20            SELECTED AI DEVICES THAT ARE REIMBURSED BY US MEDICARE
・     TABLE 21            DIABETIC RETINOPATHY DIAGNOSIS CODING AND REIMBURSEMENT
5.17.1            REIMBURSEMENT FOR AI SOFTWARE IN RADIOLOGY

6      ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET,  BY COMPONENT

6.1             INTRODUCTION
・     TABLE 22            AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・     TABLE 23            AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
6.2             SOFTWARE
6.2.1              USE OF AI PLATFORMS IN SOFTWARE TO ENHANCE DECISION-MAKING AND SIMPLIFY WORKFLOWS
・     TABLE 24            AI IN MEDICAL DIAGNOSTICS SOFTWARE MARKET, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 25            AI IN MEDICAL DIAGNOSTICS SOFTWARE MARKET, BY COUNTRY,  2022–2028 (USD MILLION)
6.3             SERVICES
6.3.1              RISING NEED TO DEPLOY AND INTEGRATE AI SYSTEMS TO SUPPORT MARKET GROWTH
・     TABLE 26            AI IN MEDICAL DIAGNOSTICS SERVICES MARKET, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 27            AI IN MEDICAL DIAGNOSTICS SERVICES MARKET, BY COUNTRY,  2022–2028 (USD MILLION)
6.4             HARDWARE
6.4.1              FREQUENT UPGRADES FOR OPTIMAL USE TO SUPPORT MARKET GROWTH
・     TABLE 28            AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 29            AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 30            AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 31            AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY COUNTRY,  2022–2028 (USD MILLION)
6.4.2              PROCESSORS
・     TABLE 32            PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 33            PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 34            PROCESSORS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・     TABLE 35            PROCESSORS MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.4.2.1            MPU
6.4.2.1.1            MPUS TO HOLD LARGEST SHARE OF PROCESSORS MARKET
・     TABLE 36            MPU MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・     TABLE 37            MPU MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.4.2.2            GPU
6.4.2.2.1            GPUS PLAY CRUCIAL ROLE IN ENHANCING ACCURACY AND EFFICACY OF IMAGING
・     TABLE 38            GPU MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・     TABLE 39            GPU MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.4.2.3            FPGA
6.4.2.3.1            WIDE USAGE POTENTIAL TO DRIVE DEMAND
・     TABLE 40            FPGA MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・     TABLE 41            FPGA MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.4.2.4            ASIC
6.4.2.4.1            RAPID OPERATIONS TO SUPPORT END-USER DEMAND
・     TABLE 42            ASIC MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・     TABLE 43            ASIC MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.4.3              MEMORY
6.4.3.1            DEVELOPMENT OF HIGH-BANDWIDTH MEMORY FOR AI APPLICATIONS TO DRIVE MARKET
・     TABLE 44            AI IN MEDICAL DIAGNOSTICS MEMORY MARKET, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 45            AI IN MEDICAL DIAGNOSTICS MEMORY MARKET, BY COUNTRY,  2022–2028 (USD MILLION)
6.4.4              NETWORKS
・     TABLE 46            AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 47            AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 48            AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 49            AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY COUNTRY,  2022–2028 (USD MILLION)
6.4.4.1            ADAPTERS
6.4.4.1.1            ADAPTERS TO HOLD LARGEST SHARE OF NETWORKS MARKET
・     TABLE 50            ADAPTERS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・     TABLE 51            ADAPTERS MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.4.4.2            SWITCHES
・     TABLE 52            SWITCHES MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・     TABLE 53            SWITCHES MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
6.4.4.3            INTERCONNECTS
6.4.4.3.1            NEED FOR EFFICIENT DATA TRANSMISSION TO DRIVE MARKET
・     TABLE 54            INTERCONNECTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION)
・     TABLE 55            INTERCONNECTS MARKET, BY COUNTRY, 2022–2028 (USD MILLION)

7      ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET,  BY APPLICATION

7.1             INTRODUCTION
・     TABLE 56            AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・     TABLE 57            AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
7.2             IN VIVO DIAGNOSTICS
7.2.1              IN VIVO DIAGNOSTICS MARKET, BY SPECIALTY
・     TABLE 58            AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY,  2017–2021 (USD MILLION)
・     TABLE 59            AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY,  2022–2028 (USD MILLION)
・     TABLE 60            AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC SPECIALTIES,  BY COUNTRY, 2017–2021 (USD MILLION)
・     TABLE 61            AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC SPECIALTIES,  BY COUNTRY, 2022–2028 (USD MILLION)
7.2.1.1            RADIOLOGY
7.2.1.1.1            AI-BASED DIAGNOSTIC TOOLS TO REDUCE WORK PRESSURE ON RADIOLOGISTS   133
・     TABLE 62            AI IN MEDICAL DIAGNOSTICS FOR RADIOLOGY, BY COUNTRY, 2017–2021 (USD MILLION)
・     TABLE 63            AI IN MEDICAL DIAGNOSTICS FOR RADIOLOGY, BY COUNTRY, 2022–2028 (USD MILLION)
7.2.1.2            CARDIOLOGY
7.2.1.2.1            RISING COMPLEXITIES ASSOCIATED WITH CVD TO DRIVE MARKET
・     TABLE 64            AI IN MEDICAL DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 65            AI IN MEDICAL DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY,  2022–2028 (USD MILLION)
7.2.1.3            NEUROLOGY
7.2.1.3.1            INCREASING PREVALENCE OF CRITICAL BRAIN DISORDERS TO DRIVE MARKET  136
・     TABLE 66            AI IN MEDICAL DIAGNOSTICS MARKET FOR NEUROLOGY, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 67            AI IN MEDICAL DIAGNOSTICS MARKET FOR NEUROLOGY, BY COUNTRY,  2022–2028 (USD MILLION)
7.2.1.4            OBSTETRICS/GYNECOLOGY
7.2.1.4.1            RISING USE OF MINIMALLY INVASIVE TECHNIQUES IN GYNECOLOGY PROCEDURES TO DRIVE MARKET

・     TABLE 68            AI IN MEDICAL DIAGNOSTICS MARKET FOR OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2017–2021 (USD MILLION)
・     TABLE 69            AI IN MEDICAL DIAGNOSTICS MARKET FOR OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2022–2028 (USD MILLION)
7.2.1.5            OPHTHALMOLOGY
7.2.1.5.1            RISING NEED FOR EARLY DETECTION & PREVENTION OF EYE DISEASES TO DRIVE MARKET
・     TABLE 70            AI IN MEDICAL DIAGNOSTICS MARKET FOR OPHTHALMOLOGY, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 71            AI IN MEDICAL DIAGNOSTICS MARKET FOR OPHTHALMOLOGY, BY COUNTRY,  2022–2028 (USD MILLION)
7.2.1.6            OTHER SPECIALTIES
・     TABLE 72            AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER SPECIALTIES, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 73            AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER SPECIALTIES, BY COUNTRY,  2022–2028 (USD MILLION)
7.2.2              IN VIVO DIAGNOSTICS MARKET, BY MODALITY
・     TABLE 74            AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY,  2017–2021 (USD MILLION)
・     TABLE 75            AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY,  2022–2028 (USD MILLION)
・     TABLE 76            AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC MODALITIES,  BY COUNTRY, 2017–2021 (USD MILLION)
・     TABLE 77            AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC MODALITIES,  BY COUNTRY, 2022–2028 (USD MILLION)
7.2.2.1            CT
7.2.2.1.1            RISING AVAILABILITY OF CARDIAC CT DEVICES WITH AI SOLUTIONS TO DRIVE MARKET
・     TABLE 78            AI IN MEDICAL DIAGNOSTICS MARKET FOR CT, BY COUNTRY, 2017–2021 (USD MILLION)
・     TABLE 79            AI IN MEDICAL DIAGNOSTICS MARKET FOR CT, BY COUNTRY, 2022–2028 (USD MILLION)
7.2.2.2            X-RAY
7.2.2.2.1            INNOVATIVE AI SOLUTIONS FOR X-RAY IMAGING BY KEY PLAYERS TO DRIVE MARKET
・     TABLE 80            AI IN MEDICAL DIAGNOSTICS MARKET FOR X-RAY, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 81            AI IN MEDICAL DIAGNOSTICS MARKET FOR X-RAY, BY COUNTRY,  2022–2028 (USD MILLION)
7.2.2.3            MRI
7.2.2.3.1            RISING TECHNOLOGICAL ADVANCEMENTS TO DRIVE ADOPTION OF  AI IN MRI
・     TABLE 82            AI IN MEDICAL DIAGNOSTICS MARKET FOR MRI, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 83            AI IN MEDICAL DIAGNOSTICS MARKET FOR MRI, BY COUNTRY,  2022–2028 (USD MILLION)
7.2.2.4            ULTRASOUND
7.2.2.4.1            INCREASING PREVALENCE OF OVARIAN CANCER TO BOOST DEMAND
・     TABLE 84            AI IN MEDICAL DIAGNOSTICS MARKET FOR ULTRASOUND, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 85            AI IN MEDICAL DIAGNOSTICS MARKET FOR ULTRASOUND, BY COUNTRY,  2022–2028 (USD MILLION)
7.2.2.5            OTHER MODALITIES
・     TABLE 86            FDA-APPROVED AI APPLICATIONS IN BREAST IMAGING
・     TABLE 87            AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER MODALITIES, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 88            AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER MODALITIES, BY COUNTRY,  2022–2028 (USD MILLION)
7.3             IN VITRO DIAGNOSTICS
7.3.1              INCREASING ADOPTION OF POC TESTING IN EMERGING ECONOMIES TO SUPPORT MARKET GROWTH
・     TABLE 89            AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 90            AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY,  2022–2028 (USD MILLION)

8      ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET,  BY END USER

8.1             INTRODUCTION
・     TABLE 91            AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・     TABLE 92            AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
8.2             HOSPITALS   156
8.2.1              INSTALLATION OF ADVANCED AI DIAGNOSTIC IMAGING SOLUTIONS TO DRIVE MARKET
・     TABLE 93            AI IN MEDICAL DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 94            AI IN MEDICAL DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY,  2022–2028 (USD MILLION)
8.3             DIAGNOSTIC IMAGING CENTERS
8.3.1              GROWING NUMBER OF PRIVATE IMAGING CENTERS TO DRIVE MARKET
・     TABLE 95            AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC IMAGING CENTERS,  BY COUNTRY, 2017–2021 (USD MILLION)
・     TABLE 96            AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC IMAGING CENTERS,  BY COUNTRY, 2022–2028 (USD MILLION)
8.4             DIAGNOSTIC LABORATORIES
8.4.1              RISING SPECIMEN TEST VOLUMES TO DRIVE MARKET
・     TABLE 97            AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 98            AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY,  2022–2028 (USD MILLION)
8.5             OTHER END USERS
・     TABLE 99            AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 100          AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY,  2022–2028 (USD MILLION)

9      ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET,  BY REGION

9.1             INTRODUCTION
・     TABLE 101          AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION, 2017–2021 (USD MILLION)
・     TABLE 102          AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION, 2022–2028 (USD MILLION)
9.2             NORTH AMERICA
9.2.1              NORTH AMERICA: RECESSION IMPACT
・     FIGURE 31          NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT
・     TABLE 103          NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 104          NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,  2022–2028 (USD MILLION)
・     TABLE 105          NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
・     TABLE 106          NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
・     TABLE 107          NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
・     TABLE 108          NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
・     TABLE 109          NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
・     TABLE 110          NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
・     TABLE 111          NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
・     TABLE 112          NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
・     TABLE 113          NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
・     TABLE 114          NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
・     TABLE 115          NORTH AMERICA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 116          NORTH AMERICA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 117          NORTH AMERICA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 118          NORTH AMERICA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 119          NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
・     TABLE 120          NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
9.2.2              US
9.2.2.1            INCREASING VOLUME OF IMAGING PROCEDURES TO DRIVE MARKET
・     TABLE 121          US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・     TABLE 122          US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・     TABLE 123          US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・     TABLE 124          US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・     TABLE 125          US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・     TABLE 126          US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・     TABLE 127          US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・     TABLE 128          US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・     TABLE 129          US: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
・     TABLE 130          US: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
・     TABLE 131          US: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 132          US: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 133          US: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 134          US: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 135          US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・     TABLE 136          US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.2.3              CANADA
9.2.3.1            RESEARCH GRANTS AND IMPROVED ACADEMICS IN RADIOLOGY TO DRIVE MARKET
・     TABLE 137          CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
・     TABLE 138          CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
・     TABLE 139          CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
・     TABLE 140          CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
・     TABLE 141          CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
・     TABLE 142          CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
・     TABLE 143          CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
・     TABLE 144          CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
・     TABLE 145          CANADA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
・     TABLE 146          CANADA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
・     TABLE 147          CANADA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 148          CANADA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 149          CANADA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 150          CANADA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 151          CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
・     TABLE 152          CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
9.3             EUROPE
9.3.1              EUROPE: RECESSION IMPACT
・     TABLE 153          EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 154          EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,  2022–2028 (USD MILLION)
・     TABLE 155          EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
・     TABLE 156          EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
・     TABLE 157          EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
・     TABLE 158          EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
・     TABLE 159          EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
・     TABLE 160          EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
・     TABLE 161          EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
・     TABLE 162          EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
・     TABLE 163          EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
・     TABLE 164          EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
・     TABLE 165          EUROPE: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 166          EUROPE: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 167          EUROPE: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 168          EUROPE: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 169          EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
・     TABLE 170          EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
9.3.2              GERMANY
9.3.2.1            RISING GOVERNMENT SUPPORT TO DRIVE ADOPTION OF AI IN MEDICAL DIAGNOSTICS
・     TABLE 171          GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
・     TABLE 172          GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
・     TABLE 173          GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
・     TABLE 174          GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
・     TABLE 175          GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
・     TABLE 176          GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
・     TABLE 177          GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
・     TABLE 178          GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
・     TABLE 179          GERMANY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
・     TABLE 180          GERMANY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
・     TABLE 181          GERMANY: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 182          GERMANY: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 183          GERMANY: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 184          GERMANY: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 185          GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
・     TABLE 186          GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
9.3.3              FRANCE
9.3.3.1            AVAILABILITY OF FUNDING FOR COMPANIES TO ENHANCE AI RESEARCH IN MEDICAL IMAGING
・     TABLE 187          FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
・     TABLE 188          FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
・     TABLE 189          FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
・     TABLE 190          FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
・     TABLE 191          FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
・     TABLE 192          FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
・     TABLE 193          FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
・     TABLE 194          FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
・     TABLE 195          FRANCE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
・     TABLE 196          FRANCE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
・     TABLE 197          FRANCE: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 198          FRANCE: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 199          FRANCE: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 200          FRANCE: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 201          FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
・     TABLE 202          FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
9.3.4              UK
9.3.4.1            INCREASING RADIOGRAPHY PROCEDURES TO DRIVE MARKET
・     TABLE 203          UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
・     TABLE 204          UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2028 (USD MILLION)
・     TABLE 205          UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・     TABLE 206          UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・     TABLE 207          UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・     TABLE 208          UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・     TABLE 209          UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017–2021 (USD MILLION)
・     TABLE 210          UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022–2028 (USD MILLION)
・     TABLE 211          UK: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
・     TABLE 212          UK: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
・     TABLE 213          UK: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 214          UK: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 215          UK: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 216          UK: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 217          UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・     TABLE 218          UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.3.5              ITALY
9.3.5.1            INCREASING VOLUME OF EHRS AND EMRS DUE TO RISING GERIATRIC POPULATION TO DRIVE DEMAND FOR AI SOLUTIONS
・     TABLE 219          ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
・     TABLE 220          ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
・     TABLE 221          ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・     TABLE 222          ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・     TABLE 223          ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・     TABLE 224          ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・     TABLE 225          ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)

・     TABLE 226          ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
・     TABLE 227          ITALY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
・     TABLE 228          ITALY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
・     TABLE 229          ITALY: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 230          ITALY: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 231          ITALY: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 232          ITALY: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 233          ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・     TABLE 234          ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.3.6              SPAIN
9.3.6.1            GROWING AWARENESS OF AI IN SPAIN TO FAVOR MARKET GROWTH
・     TABLE 235          SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
・     TABLE 236          SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
・     TABLE 237          SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・     TABLE 238          SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・     TABLE 239          SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・     TABLE 240          SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・     TABLE 241          SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
・     TABLE 242          SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
・     TABLE 243          SPAIN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
・     TABLE 244          SPAIN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
・     TABLE 245          SPAIN: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 246          SPAIN: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 247          SPAIN: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 248          SPAIN: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 249          SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017–2021 (USD MILLION)
・     TABLE 250          SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022–2028 (USD MILLION)
9.3.7              REST OF EUROPE
・     TABLE 251          REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
・     TABLE 252          REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
・     TABLE 253          REST OF EUROPE: AI IN MEDICA DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
・     TABLE 254          REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
・     TABLE 255          REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
・     TABLE 256          REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
・     TABLE 257          REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
・     TABLE 258          REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
・     TABLE 259          REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
・     TABLE 260          REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
・     TABLE 261          REST OF EUROPE: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 262          REST OF EUROPE: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 263          REST OF EUROPE: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 264          REST OF EUROPE: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 265          REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
・     TABLE 266          REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
9.4             ASIA PACIFIC
9.4.1              ASIA PACIFIC: RECESSION IMPACT
・     FIGURE 32          ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT
・     TABLE 267          ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,  2017–2021 (USD MILLION)
・     TABLE 268          ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,  2022–2028 (USD MILLION)
・     TABLE 269          ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
・     TABLE 270          ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
・     TABLE 271          ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
・     TABLE 272          ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
・     TABLE 273          ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
・     TABLE 274          ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
・     TABLE 275          ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
・     TABLE 276          ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
・     TABLE 277          ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
・     TABLE 278          ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
・     TABLE 279          ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 280          ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 281          ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 282          ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 283          ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
・     TABLE 284          ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
9.4.2              CHINA
9.4.2.1            RISING USE OF AI IN CLINICAL DECISION-MAKING TO DRIVE MARKET
・     TABLE 285          CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
・     TABLE 286          CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
・     TABLE 287          CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
・     TABLE 288          CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
・     TABLE 289          CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
・     TABLE 290          CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
・     TABLE 291          CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
・     TABLE 292          CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
・     TABLE 293          CHINA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
・     TABLE 294          CHINA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
・     TABLE 295          CHINA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 296          CHINA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 297          CHINA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 298          CHINA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 299          CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
・     TABLE 300          CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
9.4.3              JAPAN
9.4.3.1            STRONG HEALTHCARE INFRASTRUCTURE TO DRIVE UPTAKE OF ADVANCED AI SOLUTIONS
・     TABLE 301          JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
・     TABLE 302          JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
・     TABLE 303          JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
・     TABLE 304          JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
・     TABLE 305          JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
・     TABLE 306          JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
・     TABLE 307          JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
・     TABLE 308          JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
・     TABLE 309          JAPAN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
・     TABLE 310          JAPAN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
・     TABLE 311          JAPAN: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 312          JAPAN: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 313          JAPAN: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 314          JAPAN: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 315          JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
・     TABLE 316          JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
9.4.4              INDIA
9.4.4.1            FAVORABLE GOVERNMENT INITIATIVES FOR R&D INVESTMENTS TO DRIVE MARKET
・     TABLE 317          INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
・     TABLE 318          INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
・     TABLE 319          INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
・     TABLE 320          INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
・     TABLE 321          INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
・     TABLE 322          INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
・     TABLE 323          INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
・     TABLE 324          INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
・     TABLE 325          INDIA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021 (USD MILLION)
・     TABLE 326          INDIA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
・     TABLE 327          INDIA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 328          INDIA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 329          INDIA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 330          INDIA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 331          INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
・     TABLE 332          INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
9.4.5              REST OF ASIA PACIFIC
・     TABLE 333          REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
・     TABLE 334          REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
・     TABLE 335          REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
・     TABLE 336          REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
・     TABLE 337          REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
・     TABLE 338          REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
・     TABLE 339          REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
・     TABLE 340          REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
・     TABLE 341          REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 342          REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 343          REST OF ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 344          REST OF ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 345          REST OF ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 346          REST OF ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 347          REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
・     TABLE 348          REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
9.5             LATIN AMERICA
9.5.1              RISING INITIATIVES TO STABILIZE HEALTHCARE SYSTEMS TO DRIVE UPTAKE OF AI-BASED TOOLS
9.5.2              LATIN AMERICA: RECESSION IMPACT
・     TABLE 349          LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
・     TABLE 350          LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
・     TABLE 351          LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2017–2021 (USD MILLION)
・     TABLE 352          LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY SPECIALTY, 2022–2028 (USD MILLION)
・     TABLE 353          LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2017–2021 (USD MILLION)
・     TABLE 354          LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS,  BY MODALITY, 2022–2028 (USD MILLION)
・     TABLE 355          LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
・     TABLE 356          LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
・     TABLE 357          LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2017–2021(USD MILLION)
・     TABLE 358          LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE,  2022–2028 (USD MILLION)
・     TABLE 359          LATIN AMERICA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 360          LATIN AMERICA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 361          LATIN AMERICA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 362          LATIN AMERICA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 363          LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
・     TABLE 364          LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)
9.6             MIDDLE EAST & AFRICA
9.6.1              GROWING HEALTHCARE EXPENDITURE FOSTER GROWTH OF AI
9.6.2              MIDDLE EAST & AFRICA: RECESSION IMPACT
・     TABLE 365          MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2017–2021 (USD MILLION)
・     TABLE 366          MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,  2022–2028 (USD MILLION)
・     TABLE 367          MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017–2021 (USD MILLION)
・     TABLE 368          MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022–2028 (USD MILLION)
・     TABLE 369          MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017–2021 (USD MILLION)
・     TABLE 370          MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022–2028 (USD MILLION)
・     TABLE 371          MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2017–2021 (USD MILLION)
・     TABLE 372          MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,  2022–2028 (USD MILLION)
・     TABLE 373          MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 374          MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 375          MIDDLE EAST & AFRICA: PROCESSORS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 376          MIDDLE EAST & AFRICA: PROCESSORS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 377          MIDDLE EAST & AFRICA: NETWORKS MARKET, BY TYPE, 2017–2021 (USD MILLION)
・     TABLE 378          MIDDLE EAST & AFRICA: NETWORKS MARKET, BY TYPE, 2022–2028 (USD MILLION)
・     TABLE 379          MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2017–2021 (USD MILLION)
・     TABLE 380          MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,  2022–2028 (USD MILLION)

10   COMPETITIVE LANDSCAPE

10.1          OVERVIEW
10.2          KEY PLAYER STRATEGIES/RIGHT TO WIN
・     TABLE 381          OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
10.3          REVENUE ANALYSIS
・     FIGURE 33          REVENUE ANALYSIS OF KEY PLAYERS, 2017–2022
10.4          MARKET SHARE ANALYSIS
・     FIGURE 34          AI IN MEDICAL DIAGNOSTICS: MARKET SHARE ANALYSIS (2022)
・     TABLE 382          AI IN MEDICAL DIAGNOSTICS MARKET: DEGREE OF COMPETITION
・     FIGURE 35          AI IN MEDICAL DIAGNOSTICS MARKET: RANKING OF KEY COMPANIES (2022)
10.5          COMPANY EVALUATION MATRIX
10.5.1            STARS
10.5.2            EMERGING LEADERS   275
10.5.3            PERVASIVE PLAYERS   275
10.5.4            PARTICIPANTS
・     FIGURE 36          AI IN MEDICAL DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX, 2022
10.5.5            COMPANY FOOTPRINT ANALYSIS
・     TABLE 383          OVERALL COMPANY FOOTPRINT (TEN PLAYERS)
・     TABLE 384          APPLICATION (IN VIVO DIAGNOSTIC MODALITIES) FOOTPRINT (TEN PLAYERS)
・     TABLE 385          REGIONAL FOOTPRINT (TEN PLAYERS)
10.6          START-UP/SME EVALUATION MATRIX
10.6.1            PROGRESSIVE COMPANIES
10.6.2            DYNAMIC COMPANIES   278
10.6.3            RESPONSIVE COMPANIES
10.6.4            STARTING BLOCKS   278
・     FIGURE 37          AI IN MEDICAL DIAGNOSTICS MARKET: START0UP/SME EVALUATION MATRIX (2022)
10.6.5            COMPETITIVE BENCHMARKING
・     TABLE 386          AI IN MEDICAL DIAGNOSTICS MARKET: DETAILED LIST OF KEY START-UPS/SMES

・     TABLE 387          AI IN MEDICAL DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (START-UPS/SMES)
10.7          COMPETITIVE SCENARIO
10.7.1            PRODUCT LAUNCHES & ENHANCEMENTS
・     TABLE 388          AI IN MEDICAL DIAGNOSTICS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2020–SEPTEMBER 2023
10.7.2            DEALS
・     TABLE 389          KEY DEALS, JANUARY 2020–SEPTEMBER 2023
10.7.3            OTHER DEVELOPMENTS
・     TABLE 390          AI IN MEDICAL DIAGNOSTICS MARKET: OTHER DEVELOPMENTS  (JANUARY 2020–SEPTEMBER 2023)

11   COMPANY PROFILES

11.1          KEY PLAYERS   284
(BUSINESS OVERVIEW, PRODUCTS/SOLUTIONS/SERVICES OFFERED, RECENT DEVELOPMENTS, MNM VIEW, KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS)*
11.1.1            MICROSOFT
・     TABLE 391          MICROSOFT: COMPANY OVERVIEW    284
・     FIGURE 38          MICROSOFT: COMPANY SNAPSHOT (2022)
11.1.2            NVIDIA CORPORATION
・     TABLE 392          NVIDIA CORPORATION: COMPANY OVERVIEW
・     FIGURE 39          NVIDIA CORPORATION: COMPANY SNAPSHOT (2022)
11.1.3            MERATIVE
・     TABLE 393          MERATIVE: COMPANY OVERVIEW    294
・     FIGURE 40          IBM: COMPANY SNAPSHOT (2021)  295
11.1.4            GOOGLE (ALPHABET, INC.)
・     TABLE 394          GOOGLE: COMPANY OVERVIEW
・     FIGURE 41          GOOGLE: COMPANY SNAPSHOT (2022)
11.1.5            INTEL CORPORATION   302
・     TABLE 395          INTEL CORPORATION: COMPANY OVERVIEW
・     FIGURE 42          INTEL CORPORATION: COMPANY SNAPSHOT (2022)
11.1.6            SIEMENS HEALTHINEERS
・     TABLE 396          SIEMENS HEALTHINEERS: COMPANY OVERVIEW
・     FIGURE 43          SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
11.1.7            GE HEALTHCARE
・     TABLE 397          GE HEALTHCARE: COMPANY OVERVIEW
・     FIGURE 44          GE HEALTHCARE: COMPANY SNAPSHOT (2022)
11.1.8            ADVANCED MICRO DEVICES, INC.
・     TABLE 398          ADVANCED MICRO DEVICES, INC.: COMPANY OVERVIEW
・     FIGURE 45          XILINX & ADVANCED MICRO DEVICES, INC.: COMPANY SNAPSHOT (2022)
11.1.9            KONINKLIJKE PHILIPS N.V.
・     TABLE 399          KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
・     FIGURE 46          KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
11.1.10         DIGITAL DIAGNOSTICS, INC.
・     TABLE 400          DIGITAL DIAGNOSTICS, INC.: COMPANY OVERVIEW
11.1.11         INFORMAI
・     TABLE 401          INFORMAI: COMPANY OVERVIEW    326
11.2          OTHER PLAYERS
11.2.1            HEARTFLOW, INC. 328
11.2.2            ENLITIC, INC.
11.2.3            AIDENCE
11.2.4            BUTTERFLY NETWORK, INC.
11.2.5            NANO X IMAGING LTD.
11.2.6            VIZ.AI, INC.
11.2.7            QUIBIM
11.2.8            QURE.AI
11.2.9            THERAPIXEL
11.2.10         AIDOC
11.2.11         LUNIT, INC.
11.2.12         ECHONOUS, INC.
11.2.13         ICOMETRIX
11.2.14         BRAINOMIX
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS/SOLUTIONS/SERVICES OFFERED, RECENT DEVELOPMENTS, MNM VIEW, KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

12             APPENDIX

△ 一番上に戻る